Back

Numab appoints Rajesh Chopra as chief scientific officer

Verifying
  • Numab appointed Rajesh Chopra, M.D., PhD, as Chief Scientific Officer.
  • Chopra brings nearly four decades of oncology, immunology and drug-development experience.
  • Numab is advancing NM81, a trispecific antibody candidate for inflammatory bowel disease.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.